Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03865472 · ClinicalTrials.gov registry record · NA
rTMS in Promoting Smoking Cessation and Preventing Relapse in Current Smokers
A NA study of Cigarette Smoker and Current Smoker, sponsored by Roswell Park Cancer Institute.
- Active
- Registry status
- NA
- Development phase
- 206
- Enrollment target
- 1
- Study location
NCT03865472: Active NA study of Cigarette Smoker and Current Smoker, sponsored by Roswell Park Cancer Institute.
NCT03865472 is a NA study of Cigarette Smoker and Current Smoker that is active but no longer recruiting, run by Roswell Park Cancer Institute. The registered enrollment target is 206 participants, below the 875-participant average among 5 other Cigarette Smoker trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03865472, a NA study of Cigarette Smoker and Current Smoker, is active but no longer recruiting, sponsored by Roswell Park Cancer Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 206 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies best dose and how well repetitive transcranial magnetic stimulation (rTMS) works in promoting smoking cessation and preventing relapse in current smokers. rTMS is a form of brain stimulation therapy that controls nerve cell activity, increases blood flow in the brain, and improves cognitive function.
Primary Outcome
Latency to relapse will be defined as the number of days from the quit day to relapse. Relapse will be defined as smoking for seven consecutive days. Will use Cox proportional-hazards (CPH) models to examine latency to relapse outcome. Ties in failure times will be handled using methods developed by Efron. Compliance with the CPH assumptions will be tested by coding the factors as time-dependent covariates.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- PROCEDURE Sham Intervention
- PROCEDURE Repetitive Transcranial Magnetic Stimulation
Study Locations (1)
New York
- Roswell Park Cancer Institute - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2018-11-10 |
| Est. Completion | 2026-11-13 |
| Phase | NA |
What the registry record for NCT03865472 still lists
NCT03865472 is an interventional study that assigns participants to a tested intervention. The registered 206 participants enrollment target is mid-sized for trials with a published cap, below the 875-participant average among 5 other Cigarette Smoker trials with a reported enrollment target (76% lower).
The record links to 3 conditions, with Cigarette Smoker appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.
NCT03865472 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03865472 about?
NCT03865472 is a clinical study titled "rTMS in Promoting Smoking Cessation and Preventing Relapse in Current Smokers". This trial studies best dose and how well repetitive transcranial magnetic stimulation (rTMS) works in promoting smoking cessation and preventing relapse in current smokers. rTMS is a form of brain stimulation therapy that controls nerve cell activity, increases blood flow in the brain, and improves...
What is the current status of trial NCT03865472?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 206 participants. The study started on 2018-11-10. Estimated completion is 2026-11-13.
What conditions does trial NCT03865472 study?
This clinical trial studies the following conditions: Cigarette Smoker, Current Smoker, Current Every Day Smoker.
What interventions are being tested in trial NCT03865472?
The interventions under investigation include: Questionnaire Administration (OTHER), Sham Intervention (PROCEDURE), Repetitive Transcranial Magnetic Stimulation (PROCEDURE).
Who is sponsoring clinical trial NCT03865472?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03865472 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cigarette Smoker
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer
RECRUITING · NA
-
Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking Cessation
ACTIVE NOT RECRUITING · NA
-
Validation of Biomarkers of Exposure and Host Response
COMPLETED · NA
-
Varenicline and Combined NRT for Smoking Cessation
ACTIVE NOT RECRUITING · Phase 4
-
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03373968 · 206 participants · Phase 2
Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study
- NCT03550391 · 206 participants · Phase 3
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
- NCT04757116 · 206 participants · NA
Post-Market Study to Assess iTind Safety in Comparison to UroLift
- NCT05675865 · 206 participants · NA
Cryoablation for Monomorphic Ventricular Tachycardia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI